Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Virovir 200mg tablets
0503021C0BCAAAB
|
Virovir | Aciclovir | Infections | No data available |
|
Virovir 400mg tablets
0503021C0BCABAC
|
Virovir | Aciclovir | Infections | No data available |
|
Virovir 800mg tablets
0503021C0BCACAD
|
Virovir | Aciclovir | Infections | No data available |
|
Vistide 375mg/5ml solution for infusion vials (Gilead)
0503022C0BBABAA
|
Vistide | Cidofovir | Infections | No data available |
|
Vistide 375mg/5ml solution for infusion vials (Imported)
0503022C0BBAAAA
|
Vistide | Cidofovir | Infections | No data available |
|
Vitekta 150mg tablets
0503010AJBBABAB
|
Vitekta | Elvitegravir | Infections | No data available |
|
Vitekta 85mg tablets
0503010AJBBAAAA
|
Vitekta | Elvitegravir | Infections | No data available |
|
Vocabria 30mg tablets
0503010AWBBAAAA
|
Vocabria | Cabotegravir | Infections | No data available |
|
Vocabria 600mg/3ml prolonged-release inj vials
0503010AWBBABAB
|
Vocabria | Cabotegravir | Infections | No data available |
|
Voractiv (Imported)
0501090S0BEABA0
|
Voractiv | Rifampicin combined preparations | Infections | No data available |
|
Voriconazole 1% eye drops
0502010D0AAAGAG
|
Voriconazole | Voriconazole | Infections | No data available |
|
Voriconazole 1% eye drops preservative free
0502010D0AAAEAE
|
Voriconazole | Voriconazole | Infections | No data available |
|
Voriconazole 200mg inj vials
0502010D0AAAFAF
|
Voriconazole | Voriconazole | Infections | No data available |
|
Voriconazole 200mg powder for solution for infusion vials
0502010D0AAACAC
|
Voriconazole | Voriconazole | Infections | No data available |
|
Vosevi 400mg/100mg/100mg tablets
0503032L0BBAAA0
|
Vosevi | Sofosbuvir/velpatasvir/voxilaprevir | Infections | No data available |
|
Xifaxan 550mg tablets
0501070X0BDAAAB
|
Xifaxan | Rifaximin | Infections | No data available |
|
Xofluza 40mg tablets
0503040D0BBAAAA
|
Xofluza | Baloxavir marboxil | Infections | No data available |
|
Xofluza 80mg tablets
0503040D0BBABAB
|
Xofluza | Baloxavir marboxil | Infections | No data available |
|
Xydalba 500mg pdr for concentrate for inf vials
0501070AFBBAAAA
|
Xydalba | Dalbavancin hydrochloride | Infections | No data available |
|
Zalcitabine 375microgram tablets
0503010X0AAABAB
|
Zalcitabine | Zalcitabine | Infections | No data available |
|
Zalcitabine 750microgram tablets
0503010X0AAAAAA
|
Zalcitabine | Zalcitabine | Infections | No data available |
|
Zeffix 5mg/ml oral solution
0503010Q0BCAAAC
|
Zeffix | Lamivudine | Infections | No data available |
|
Zentel 400mg chewable tablets
0505030A0BCAAAB
|
Zentil | Albendazole | Infections | No data available |
|
Zepatier 50mg/100mg tablets
0503032I0BBAAAA
|
Zepatier | Elbasvir/grazoprevir | Infections | No data available |
|
Zerit 15mg capsules
0503010S0BBAAAA
|
Zerit | Stavudine | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.